Seizures are rare, and usually occur when they do in those with an underlying CNS disorder.

There are studies investigating the relation of neuropeptides and CNS disorders including depression.

Cell death is a characteristic of acute CNS disorders as well as neurodegenerative disease.

Despite differences in symptoms or injuries associated with CNS disorders, many of the mechanisms behind neurodegeneration are the same.

Glutamate excitotoxicity is one of the most important mechanisms known to trigger cell death in CNS disorders.

Glutamate antagonists are the primary treatment used to prevent or help control excitotoxicity in CNS disorders.

Creutzfeldt-Jakob disease - degenerative CNS disorder, named after the authors who first described it.

Most common CNS disorders are highly polygenic in nature; that is, they are controlled by complex interactions between numerous gene products.

It is being developed for the treatment of Parkinson's disease, but may also have potential for other CNS disorders.

In early 2012, Otsuka announced it would focus its "future operations on CNS disorders and oncology".